Pulmonary hypertension (PH) is a pathophysiological disorder that may involve multiple
clinical conditions and may be associated with a variety of cardiovascular and respiratory …

Atrial secondary tricuspid regurgitation (A-STR) is a distinct phenotype of secondary
tricuspid regurgitation with predominant dilation of the right atrium and normal right and left …

Abstract Background and Aims For patients with symptomatic, severe tricuspid regurgitation
(TR), early results of transcatheter tricuspid valve (TV) intervention studies have shown …

Interest in the pathophysiology, etiology, management, and outcomes of patients with
tricuspid regurgitation (TR) has grown in the wake of multiple natural history studies showing …

Right ventricular (RV) size and function assessed by multimodality imaging are associated
with outcomes in a variety of cardiovascular diseases. Understanding RV anatomy and …

Valvular heart disease is common and its prevalence is rapidly increasing worldwide.
Effective medical therapies are insufficient and treatment was historically limited to the …

Right ventricular (RV) function and its adaptation to increased afterload [RV–pulmonary
arterial (PA) coupling] are crucial in various types of pulmonary hypertension, determining …

Heart failure with preserved ejection fraction (HFpEF) is associated with high morbidity and
mortality. Important risk factors for the development of HFpEF are similar to risk factors for the …

Transcatheter tricuspid valve interventions (TTVI) are emerging as alternatives to surgery in
high-risk patients with isolated or concomitant tricuspid regurgitation. The development of …

Tricuspid valve disease is an often underrecognized clinical problem that is associated with
significant morbidity and mortality. Unfortunately, patients will often present late in their …